Figure S6 from Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer
Year: 2025
Type: other
Abstract: Figure S6. KRAS mutated tumors have an increased CD cytotoxicity score, which is lost with STK11 co-mutation
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4408968582
